Generation of a transgenic model to address regulation and function of the human neurokinin 1 receptor (NK1R)

A. S. Vasiliou, A. MacKenzie, R. Morris, L. McLaughlin, V. J. Bubb, K. Haddley, J. P. Quinn

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We have generated mouse transgenic lines using yeast artificial chromosome (YAC) technology which demonstrate expression from the human NK1 receptor (NK1R) locus. We introduced a 380 kb fragment encompassing the human NK1R gene and flanking regions which we hoped would recapitulate the expected endogenous expression of the human gene. To visualise this expression the NK1 locus co-expresses the green fluorescence protein gene (GFP) under the control of an internal ribosome entry site (IRES) sequence. We have generated five mouse lines that express the human NK1 receptor gene with and without the marker gene. All the lines incorporating the marker gene appear to exhibit the same expression pattern in analysis of selected anatomical regions throughout the mouse. The lack of a human specific NK1R antibody determined that we could not distinguish between expression of the transgene and endogenous NK1R. Our analysis has shown transgene expression in brain areas known to express NK1R in human such as the hippocampus and caudate putamen. The majority of these cells were also positive for GFP fluorescence. These transgenic lines may prove a good pre-clinical model as drugs can be addressed against both the human receptor and modulators of its expression in vivo. (C) 2007 Elsevier Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)195-205
Number of pages11
JournalNeuropeptides
Volume41
Issue number4
Early online date18 Jun 2007
DOIs
Publication statusPublished - Aug 2007

Keywords

  • Tachykinins
  • substance P
  • NK1R
  • YAC
  • transgenic
  • anxiety
  • yeast artificial chromosome
  • receptor gene-expression
  • substance-P
  • affective-disorders
  • trigeminal nucleus
  • peripheral-tissues
  • binding-sites
  • spinal-cord
  • human brain
  • mice

Cite this

Generation of a transgenic model to address regulation and function of the human neurokinin 1 receptor (NK1R). / Vasiliou, A. S.; MacKenzie, A.; Morris, R.; McLaughlin, L.; Bubb, V. J.; Haddley, K.; Quinn, J. P.

In: Neuropeptides, Vol. 41, No. 4, 08.2007, p. 195-205.

Research output: Contribution to journalArticle

Vasiliou, A. S. ; MacKenzie, A. ; Morris, R. ; McLaughlin, L. ; Bubb, V. J. ; Haddley, K. ; Quinn, J. P. / Generation of a transgenic model to address regulation and function of the human neurokinin 1 receptor (NK1R). In: Neuropeptides. 2007 ; Vol. 41, No. 4. pp. 195-205.
@article{559c17ce4d1042f3ae52a64366df225a,
title = "Generation of a transgenic model to address regulation and function of the human neurokinin 1 receptor (NK1R)",
abstract = "We have generated mouse transgenic lines using yeast artificial chromosome (YAC) technology which demonstrate expression from the human NK1 receptor (NK1R) locus. We introduced a 380 kb fragment encompassing the human NK1R gene and flanking regions which we hoped would recapitulate the expected endogenous expression of the human gene. To visualise this expression the NK1 locus co-expresses the green fluorescence protein gene (GFP) under the control of an internal ribosome entry site (IRES) sequence. We have generated five mouse lines that express the human NK1 receptor gene with and without the marker gene. All the lines incorporating the marker gene appear to exhibit the same expression pattern in analysis of selected anatomical regions throughout the mouse. The lack of a human specific NK1R antibody determined that we could not distinguish between expression of the transgene and endogenous NK1R. Our analysis has shown transgene expression in brain areas known to express NK1R in human such as the hippocampus and caudate putamen. The majority of these cells were also positive for GFP fluorescence. These transgenic lines may prove a good pre-clinical model as drugs can be addressed against both the human receptor and modulators of its expression in vivo. (C) 2007 Elsevier Ltd. All rights reserved.",
keywords = "Tachykinins, substance P, NK1R, YAC, transgenic, anxiety, yeast artificial chromosome, receptor gene-expression, substance-P, affective-disorders, trigeminal nucleus, peripheral-tissues, binding-sites, spinal-cord, human brain, mice",
author = "Vasiliou, {A. S.} and A. MacKenzie and R. Morris and L. McLaughlin and Bubb, {V. J.} and K. Haddley and Quinn, {J. P.}",
year = "2007",
month = "8",
doi = "10.1016/j.npep.2007.04.005",
language = "English",
volume = "41",
pages = "195--205",
journal = "Neuropeptides",
issn = "0143-4179",
publisher = "Churchill Livingstone",
number = "4",

}

TY - JOUR

T1 - Generation of a transgenic model to address regulation and function of the human neurokinin 1 receptor (NK1R)

AU - Vasiliou, A. S.

AU - MacKenzie, A.

AU - Morris, R.

AU - McLaughlin, L.

AU - Bubb, V. J.

AU - Haddley, K.

AU - Quinn, J. P.

PY - 2007/8

Y1 - 2007/8

N2 - We have generated mouse transgenic lines using yeast artificial chromosome (YAC) technology which demonstrate expression from the human NK1 receptor (NK1R) locus. We introduced a 380 kb fragment encompassing the human NK1R gene and flanking regions which we hoped would recapitulate the expected endogenous expression of the human gene. To visualise this expression the NK1 locus co-expresses the green fluorescence protein gene (GFP) under the control of an internal ribosome entry site (IRES) sequence. We have generated five mouse lines that express the human NK1 receptor gene with and without the marker gene. All the lines incorporating the marker gene appear to exhibit the same expression pattern in analysis of selected anatomical regions throughout the mouse. The lack of a human specific NK1R antibody determined that we could not distinguish between expression of the transgene and endogenous NK1R. Our analysis has shown transgene expression in brain areas known to express NK1R in human such as the hippocampus and caudate putamen. The majority of these cells were also positive for GFP fluorescence. These transgenic lines may prove a good pre-clinical model as drugs can be addressed against both the human receptor and modulators of its expression in vivo. (C) 2007 Elsevier Ltd. All rights reserved.

AB - We have generated mouse transgenic lines using yeast artificial chromosome (YAC) technology which demonstrate expression from the human NK1 receptor (NK1R) locus. We introduced a 380 kb fragment encompassing the human NK1R gene and flanking regions which we hoped would recapitulate the expected endogenous expression of the human gene. To visualise this expression the NK1 locus co-expresses the green fluorescence protein gene (GFP) under the control of an internal ribosome entry site (IRES) sequence. We have generated five mouse lines that express the human NK1 receptor gene with and without the marker gene. All the lines incorporating the marker gene appear to exhibit the same expression pattern in analysis of selected anatomical regions throughout the mouse. The lack of a human specific NK1R antibody determined that we could not distinguish between expression of the transgene and endogenous NK1R. Our analysis has shown transgene expression in brain areas known to express NK1R in human such as the hippocampus and caudate putamen. The majority of these cells were also positive for GFP fluorescence. These transgenic lines may prove a good pre-clinical model as drugs can be addressed against both the human receptor and modulators of its expression in vivo. (C) 2007 Elsevier Ltd. All rights reserved.

KW - Tachykinins

KW - substance P

KW - NK1R

KW - YAC

KW - transgenic

KW - anxiety

KW - yeast artificial chromosome

KW - receptor gene-expression

KW - substance-P

KW - affective-disorders

KW - trigeminal nucleus

KW - peripheral-tissues

KW - binding-sites

KW - spinal-cord

KW - human brain

KW - mice

U2 - 10.1016/j.npep.2007.04.005

DO - 10.1016/j.npep.2007.04.005

M3 - Article

VL - 41

SP - 195

EP - 205

JO - Neuropeptides

JF - Neuropeptides

SN - 0143-4179

IS - 4

ER -